INVESTOR CALL: Virtualware's CEO to present Annual Report to shareholders
11 avr. 2024 02h00 HE
|
VIRTUALWARE 2007 SA
Bilbao, April 11 - Spanish listed company Virtualware (EPA:MLVIR), European leader in the industrial virtual reality sector, invites its shareholders to a meeting to review the Annual Results and...
Virtual Reality company Virtualware to start trading in Euronext Paris on April 20
03 avr. 2023 04h23 HE
|
Virtualware
BILBAO, Spain and PARIS, April 03, 2023 (GLOBE NEWSWIRE) -- European company Virtualware, one of the European leaders in the Virtual Reality industry, will start trading on Euronext Paris on April...
NEURONES : Stabilité (+ 0,2%) du chiffre d’affaires au 1er semestre 2020
04 août 2020 11h40 HE
|
NEURONES
INFORMATION PRESSE Nanterre, le 4 août 2020 (après Bourse)Rubrique : C.A. 1er semestre 2020 Stabilité (+ 0,2%) du chiffre d’affaires au 1er semestre...
NEURONES: Revenues stable (+0.2%) in 1st half of 2020
04 août 2020 11h40 HE
|
NEURONES
PRESS INFORMATION Nanterre, August 4, 2020 (after the closing of the stock exchange)Heading: 1st half 2020 revenues Revenues stable (+0.2%) in 1st half of 2020 Revenues (in millions...
Innate Pharma announces the exercise in full of the option granted to the underwriters of its global offering and Nasdaq global select market listing to purchase 1,875,000 additional ADSs
18 oct. 2019 10h00 HE
|
INNATE PHARMA
Marseille, France, October 17, 2019, 8:30 AM CEST INNATE PHARMA S.A. (Euronext Paris: IPH – ISIN: FR0010331421) (“Innate” or the “Company”), a French biotechnology company focused on discovering,...
Innate Pharma annonce la suspension du cours de ses actions ordinaires sur Euronext Paris
17 oct. 2019 02h30 HE
|
INNATE PHARMA
Marseille, le 17 octobre 2019, 8h30 INNATE PHARMA S.A. (la « Société » - Euronext Paris : FR0010331421 – IPH), société de biotechnologie française spécialisée dans la découverte, le développement et...
Innate Pharma announces trading halt of its ordinary shares on Euronext Paris
17 oct. 2019 02h30 HE
|
INNATE PHARMA
Marseille, France, October 17, 2019, 8:30 AM CEST INNATE PHARMA S.A. (Euronext Paris: IPH – ISIN: FR0010331421) (“Innate” or the “Company”), a French biotechnology company focused on discovering,...
Constellium N.V. Announces Delisting From Euronext Paris
31 janv. 2018 02h00 HE
|
Constellium Paris
AMSTERDAM, The Netherlands, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Constellium N.V. (NYSE:CSTM) (Euronext Paris:CSTM) (« Constellium ») today announced that the request by Constellium to delist its...
Isocol Holdings AG applies to list on Euronext exchange in Paris
19 juil. 2016 19h42 HE
|
Isocol Pty Ltd
ZURICH, Switzerland, July 20, 2016 (GLOBE NEWSWIRE) -- Isocol Holdings AG has applied to list on the Euronext Paris (Marché Libre) exchange. The proposed listing forms part of the company’s...